Published in Gene Therapy Weekly, November 25th, 1996
The (alpha)2 -macroglobulin receptor/low density lipoprotein receptor-related protein ((alpha)2 -MR/LRP) is unique in its ability to bind and endocytose a variety of very different ligands. These include lipoprotein remnants, cytokines/growth factors, and proteases (in complex with (alpha)2 -macrogobulin), as well as plasminogen activators complexed with inhibitors. (alpha)2 -MR/LRP is a very large cell surface receptor (mol. wt 600 kDa) that is capable of internalizing its ligands...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.